Advances in Alzheimer’s disease clinical trials are accelerating rapidly, leading to new insights and disease-modifying therapies, but how does the field continue bolstering that momentum? For Dr. Rema Raman, it’s through improving inclusivity and training for early-career researchers. Recorded at the 2024 Alzheimer’s Disease & Related Dementias Research Day, Dr. Raman joins the podcast to discuss her work in research recruitment and retention, the importance of training the next generation of clinical trialists in dementia research with the IMPACT-AD program and more from her featured presentation.
Guest: Rema Raman, PhD, co-director, Institute of Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD), director, section of biostatistics, section of participant recruitment & retention section, Alzheimer’s Therapeutic Research Institute, professor of neurology, University of Southern California
Show NotesWatch our YouTube page for upcoming recordings of Dr. Raman’s presentation and other featured speakers at Alzheimer’s Disease & Related Dementias Research Day 2024.
Learn more about Alzheimer’s Disease & Related Dementias Research Day on our website.
Learn more about the Institute of Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD) on their website.
Learn more about Dr. Raman at her bio on the Keck School of Medicine website.
Connect with usFind transcripts and more at our website.
Email Dementia Matters: dementiamatters@medicine.wisc.edu
Follow us on Facebook and Twitter.
Subscribe to the Wisconsin Alzheimer’s Disease Research Center’s e-newsletter.
Enjoy Dementia Matters? Consider making a gift to the Dementia Matters fund through the UW Initiative to End Alzheimer’s. All donations go toward outreach and production.
Bioenergetics: How Mitochondria Affects Alzheimer’s Disease and Aging
Looking Toward the Future: How Preclinical Alzheimer’s Disease Biomarker Disclosures Impact Society
Mixed Dementia, Explained
The Case for Disclosing Biomarker Results to Alzheimer’s Research Participants
Promoting Open Science and Community Engagement with the National Institute on Aging
Moving into the Digital Era of Alzheimer’s Disease Research
National Efforts to Standardize Brain Scan Data for More Accurate Alzheimer’s Risk Predictions
Protecting Participant Privacy and Making Predictions Using Alzheimer’s Data
The Future of Sharing and Accessing Alzheimer’s Disease Data
Introducing the National Alzheimer’s Coordinating Center
Study Shows APOE e4 Not Associated with Alzheimer’s Disease in American Indian Populations
Improving Registries and Representation in Alzheimer’s Disease Research
Highlights from the 2022 Alzheimer’s Association International Conference
COVID-19 and Its Effects on the Brain
Apathy and Alzheimer’s Disease: Plenary Preview with Dr. Krista Lanctôt
Scientific Importance of Diversity in Alzheimer’s Disease Research
Delirium and Dementia: Plenary Preview with Dr. Sharon Inouye
Non-Pharmacological Care for People with MCI and Dementia: Plenary Preview with Dr. Linda Lam
Opening Doors to Research Participants: Making Scientific Conferences Accessible to the Public
The World’s Largest Forum for Alzheimer’s Research: Introducing the AAIC 2022 Special Series
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Life in the A-Zone
Caregiver Storyteller - About Alzheimer’s and Dementia Caregiving
The Life, Love, and Alzheimer’s Podcast
Fading Memories: Alzheimer’s/Dementia Caregiver Support
Alzheimer’s Speaks